News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
CARMAT SAS Sets $89.81 Million IPO to Fund Artificial Heart on July 13
July 8, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
PARIS, July 7 (Reuters) - French artificial heart developer Carmat, which counts EADS (EAD.PA) amongst its shareholders, has set the date of its initial public offering for July 13 as it seeks extra funds to bring its product to market.
Twitter
LinkedIn
Facebook
Email
Print
IPO
Europe
MORE ON THIS TOPIC
Deals
Lilly Doubles Down on Insilico’s AI Medicines, Bets Up to $2.75B
March 30, 2026
·
2 min read
·
Tristan Manalac
Mergers & acquisitions
Novartis Keeps Deals Coming With $2B Excellergy Takeover
March 27, 2026
·
2 min read
·
Tristan Manalac
Mergers & acquisitions
Merck To Buy Terns, ‘Unprecedented’ Leukemia Drug for $6.7B as Keytruda Cliff Looms
March 25, 2026
·
3 min read
·
Tristan Manalac
Mergers & acquisitions
Gilead Drops $2.1B for Ouro, Hopes To Split Cost with Galapagos
March 24, 2026
·
3 min read
·
Tristan Manalac